Md. biopharm gets $1M NIH grant to study drug

Neuralstem Inc., a biopharmaceutical company, recently received a grant worth up to nearly $1 million from the National Institutes of Health. The Germantown company received the research grant, to evaluate over two years the ability of its small molecule compound, NSI-189 to prevent and treat diabetic neuropathy. In a previous study, NSI-189 was shown to significantly protect motor and sensory nerve function ...

Complete access to news articles on this website is available to subscribers only. Subscribers may login at the login tab, below. Others may join our audience of successful Marylanders with a subscription today.

Enter your user name and password in the fields above to gain access to the subscriber content on this site.

Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.

To inquire about group subscriptions or an enterprise site license for your organization, contact Tracy Bumba.

If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?